|
Chromophore-Assisted Light Inactivation
|
D061885 |
[A technique for causing a targeted loss of molecular function from REACTIVE OXYGEN SPECIES that are formed by the illumination of dyes placed in the immediate vicinity of the target molecule.
] |
|
Streptococcus Phages
|
B04.123.850 |
|
|
Neuromuscular Monitoring
|
D061886 |
[The use of peripheral nerve stimulation to assess transmission at the NEUROMUSCULAR JUNCTION, especially in the response to anesthetics, such as the intensity of NEUROMUSCULAR BLOCKADE by NEUROMUSCULAR BLOCKING AGENTS.
, Measuring the response of a muscle to four consecutive stimuli delivered along the path of the muscle's innervating nerve to test the level of NEUROMUSCULAR BLOCKADE.
] |
|
Casein Kinase Idelta
|
D08.811.913.696.620.682.700.140.300.200 |
|
|
Casein Kinase I
|
D08.811.913.696.620.682.700.140.300 |
|
|
Emotional Regulation
|
F01.145.813.595.500 |
|
|
Hyperlipoproteinemia Type III
|
C16.320.565.398.483 |
|
|
Mandibular Advancement
|
E06.645.500 |
|
|
Hyperlipoproteinemia Type II
|
C16.320.565.398.481 |
|
|
Infarction, Middle Cerebral Artery
|
C14.907.253.092.477.200.450 |
|
|
Transplantation Tolerance
|
G12.535.425.955 |
|
|
Hyperlipoproteinemia Type IV
|
C16.320.565.398.487 |
|
|
Microarray Analysis
|
D046228 |
[The simultaneous analysis, on a microchip, of multiple samples or targets arranged in an array format.
] |
|
N-Terminal Acetyltransferase B
|
D08.811.913.050.134.423.200 |
|
|
N-Terminal Acetyltransferases
|
D08.811.913.050.134.423 |
|
|
Orbital Neoplasms
|
C11.675.659 |
|
|
Orbital Diseases
|
C11.675 |
|
|
Tigecycline
|
D04.615.562.900.937 |
|
|
Education of Intellectually Disabled
|
I02.233.213.400 |
|
|
Education, Special
|
I02.233.213 |
|
